Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$115.19 - $132.77 $4,262 - $4,912
-37 Reduced 2.08%
1,739 $209,000
Q4 2023

Feb 14, 2024

SELL
$114.26 - $136.0 $4,570 - $5,440
-40 Reduced 2.2%
1,776 $218,000
Q2 2023

Aug 14, 2023

SELL
$122.5 - $147.16 $5,390 - $6,475
-44 Reduced 2.37%
1,816 $225,000
Q1 2023

May 15, 2023

SELL
$133.98 - $160.47 $1,473 - $1,765
-11 Reduced 0.59%
1,860 $272,000
Q4 2022

Feb 14, 2023

SELL
$129.72 - $159.85 $11,026 - $13,587
-85 Reduced 4.35%
1,871 $298,000
Q1 2022

May 16, 2022

BUY
$129.64 - $160.7 $9,204 - $11,409
71 Added 3.77%
1,956 $304,000
Q3 2021

Nov 15, 2021

SELL
$128.64 - $184.79 $235,539 - $338,350
-1,831 Reduced 49.27%
1,885 $245,000
Q2 2021

Aug 16, 2021

SELL
$160.2 - $186.42 $16,019 - $18,642
-100 Reduced 2.62%
3,716 $660,000
Q1 2021

May 14, 2021

SELL
$150.19 - $173.5 $93,568 - $108,090
-623 Reduced 14.03%
3,816 $627,000
Q4 2020

Feb 16, 2021

SELL
$140.71 - $165.05 $5,628 - $6,602
-40 Reduced 0.89%
4,439 $733,000
Q3 2020

Nov 13, 2020

SELL
$105.46 - $144.13 $16,346 - $22,340
-155 Reduced 3.34%
4,479 $639,000
Q2 2020

Aug 07, 2020

SELL
$95.68 - $121.88 $11,864 - $15,113
-124 Reduced 2.61%
4,634 $511,000
Q1 2020

May 08, 2020

SELL
$87.74 - $152.74 $156,615 - $272,640
-1,785 Reduced 27.28%
4,758 $475,000
Q4 2019

Feb 14, 2020

SELL
$117.65 - $153.73 $6,588 - $8,608
-56 Reduced 0.85%
6,543 $977,000
Q3 2019

Nov 13, 2019

BUY
$125.18 - $143.24 $7,010 - $8,021
56 Added 0.86%
6,599 $846,000
Q2 2019

Aug 13, 2019

SELL
$125.55 - $144.48 $13,936 - $16,037
-111 Reduced 1.67%
6,543 $933,000
Q1 2019

May 15, 2019

BUY
$121.81 - $142.95 $14,982 - $17,582
123 Added 1.88%
6,654 $951,000
Q4 2018

Feb 14, 2019

BUY
$115.94 - $166.74 $12,637 - $18,174
109 Added 1.7%
6,531 $810,000
Q3 2018

Nov 14, 2018

BUY
$161.01 - $180.57 $8,372 - $9,389
52 Added 0.82%
6,422 $1.08 Million
Q2 2018

Aug 14, 2018

BUY
$146.33 - $183.18 $5,121 - $6,411
35 Added 0.55%
6,370 $1.1 Million
Q1 2018

May 15, 2018

SELL
$135.59 - $157.16 $7,186 - $8,329
-53 Reduced 0.83%
6,335 $957,000
Q4 2017

Feb 14, 2018

SELL
$131.06 - $150.39 $31,323 - $35,943
-239 Reduced 3.61%
6,388 $860,000
Q3 2017

Nov 14, 2017

BUY
$142.62 - $155.6 $945,142 - $1.03 Million
6,627
6,627 $969,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Brown Capital Management LLC Portfolio

Follow Brown Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brown Capital Management LLC with notifications on news.